Published in Chest on June 01, 2013
Novel radiotherapy approaches for lung cancer: combining radiation therapy with targeted and immunotherapies. Transl Lung Cancer Res (2015) 0.99
Stereotactic body radiation therapy (SBRT) for lung cancer patients previously treated with conventional radiotherapy: a review. Radiat Oncol (2014) 0.92
Photodynamic therapy for lung cancer and malignant pleural mesothelioma. Semin Oncol (2014) 0.92
Additional data in the debate on stage I non-small cell lung cancer: surgery versus stereotactic ablative radiotherapy. Ann Transl Med (2015) 0.88
Timing and characteristics of radiation pneumonitis after stereotactic body radiotherapy for peripherally located stage I lung cancer. Int J Clin Oncol (2014) 0.79
Regulatory T Cells Contribute to the Inhibition of Radiation-Induced Acute Lung Inflammation via Bee Venom Phospholipase A₂ in Mice. Toxins (Basel) (2016) 0.77
Time, Dose, and Volume Responses in a Mouse Pulmonary Injury Model Following Ablative Irradiation. Lung (2015) 0.76
Stereotactic Radiotherapy for Stage I Small Cell Lung Cancer. Oncologist (2016) 0.75
Standardized Herbal Formula PM014 Inhibits Radiation-Induced Pulmonary Inflammation in Mice. Sci Rep (2017) 0.75
Comparative analysis of thermoplastic masks versus vacuum cushions in stereotactic body radiotherapy. Radiat Oncol (2015) 0.75
Definitive surgery and intraoperative photodynamic therapy: a prospective study of local control and survival for patients with pleural dissemination of non-small cell lung cancer. Proc SPIE Int Soc Opt Eng (2014) 0.75
Radiation-induced changes in the glycome of endothelial cells with functional consequences. Sci Rep (2017) 0.75
Acute and Late Toxicities of Concurrent Chemoradiotherapy for Locally-Advanced Non-Small Cell Lung Cancer. Cancers (Basel) (2017) 0.75
Harnessing the potential synergy of combining radiation therapy and immunotherapy for thoracic malignancies. Transl Lung Cancer Res (2017) 0.75
Immunotherapy and radiation therapy for malignant pleural mesothelioma. Transl Lung Cancer Res (2017) 0.75
Predicting risk factors for radiation pneumonitis after stereotactic body radiation therapy for primary or metastatic lung tumours. Br J Radiol (2017) 0.75
Photodynamic therapy of cancer: an update. CA Cancer J Clin (2011) 6.08
Short-term and long-term health risks of nuclear-power-plant accidents. N Engl J Med (2011) 4.82
Topographical continuity of bacterial populations in the healthy human respiratory tract. Am J Respir Crit Care Med (2011) 4.78
Intravenous delivery of a multi-mechanistic cancer-targeted oncolytic poxvirus in humans. Nature (2011) 4.61
Determination of the distribution of light, optical properties, drug concentration, and tissue oxygenation in-vivo in human prostate during motexafin lutetium-mediated photodynamic therapy. J Photochem Photobiol B (2004) 3.09
Predicting radiation pneumonitis after chemoradiation therapy for lung cancer: an international individual patient data meta-analysis. Int J Radiat Oncol Biol Phys (2012) 2.80
Hypoxia is important in the biology and aggression of human glial brain tumors. Clin Cancer Res (2004) 2.73
National Institutes of Health State-of-the-Science Conference statement: Diagnosis and Management of Ductal Carcinoma In Situ September 22-24, 2009. J Natl Cancer Inst (2010) 2.59
Optical properties of human prostate at 732 nm measured in mediated photodynamic therapy. Photochem Photobiol (2005) 2.33
Patient-reported outcomes after 3-dimensional conformal, intensity-modulated, or proton beam radiotherapy for localized prostate cancer. Cancer (2013) 2.10
Phase II trial of pleural photodynamic therapy and surgery for patients with non-small-cell lung cancer with pleural spread. J Clin Oncol (2004) 1.93
In vivo light dosimetry for motexafin lutetium-mediated PDT of recurrent breast cancer. Lasers Surg Med (2002) 1.86
Photodynamic therapy and the evolution of a lung-sparing surgical treatment for mesothelioma. Ann Thorac Surg (2011) 1.80
In vivo optical properties of normal canine prostate at 732 nm using motexafin lutetium-mediated photodynamic therapy. Photochem Photobiol (2003) 1.76
Explicit dosimetry for photodynamic therapy: macroscopic singlet oxygen modeling. J Biophotonics (2010) 1.71
Outpatient management of malignant pleural effusions with small-bore, tunneled pleural catheters. Respiration (2005) 1.70
Interstitial fluorescence spectroscopy in the human prostate during motexafin lutetium-mediated photodynamic therapy. Photochem Photobiol (2007) 1.69
A phase I study of Foscan-mediated photodynamic therapy and surgery in patients with mesothelioma. Ann Thorac Surg (2003) 1.66
Lung-enriched organisms and aberrant bacterial and fungal respiratory microbiota after lung transplant. Am J Respir Crit Care Med (2012) 1.64
Comparative measurements of hypoxia in human brain tumors using needle electrodes and EF5 binding. Cancer Res (2004) 1.59
Patterns and levels of hypoxia in head and neck squamous cell carcinomas and their relationship to patient outcome. Int J Radiat Oncol Biol Phys (2007) 1.55
Nelfinavir down-regulates hypoxia-inducible factor 1alpha and VEGF expression and increases tumor oxygenation: implications for radiotherapy. Cancer Res (2006) 1.50
Phosphatase and tensin homologue deficiency in glioblastoma confers resistance to radiation and temozolomide that is reversed by the protease inhibitor nelfinavir. Cancer Res (2007) 1.47
Farnesyltransferase inhibitors: an overview of the results of preclinical and clinical investigations. Cancer Res (2003) 1.46
The HIV protease inhibitor nelfinavir downregulates Akt phosphorylation by inhibiting proteasomal activity and inducing the unfolded protein response. Neoplasia (2007) 1.40
Radical pleurectomy and intraoperative photodynamic therapy for malignant pleural mesothelioma. Ann Thorac Surg (2012) 1.39
Epidermal growth factor receptor inhibition modulates the microenvironment by vascular normalization to improve chemotherapy and radiotherapy efficacy. PLoS One (2009) 1.37
A phase I study of topical Tempol for the prevention of alopecia induced by whole brain radiotherapy. Clin Cancer Res (2004) 1.37
The prevalence of major depression or dysthymia among aged Medicare Fee-for-Service beneficiaries. Int J Geriatr Psychiatry (2002) 1.30
Predicting esophagitis after chemoradiation therapy for non-small cell lung cancer: an individual patient data meta-analysis. Int J Radiat Oncol Biol Phys (2013) 1.29
Central-airway necrosis after stereotactic body-radiation therapy. N Engl J Med (2012) 1.27
Motexafin lutetium-photodynamic therapy of prostate cancer: short- and long-term effects on prostate-specific antigen. Clin Cancer Res (2008) 1.26
In vivo reflectance measurement of optical properties, blood oxygenation and motexafin lutetium uptake in canine large bowels, kidneys and prostates. Phys Med Biol (2002) 1.23
Does registration of PET and planning CT images decrease interobserver and intraobserver variation in delineating tumor volumes for non-small-cell lung cancer? Int J Radiat Oncol Biol Phys (2005) 1.23
Broadband reflectance measurements of light penetration, blood oxygenation, hemoglobin concentration, and drug concentration in human intraperitoneal tissues before and after photodynamic therapy. J Biomed Opt (2005) 1.22
Updated results of a phase I trial of motexafin lutetium-mediated interstitial photodynamic therapy in patients with locally recurrent prostate cancer. J Environ Pathol Toxicol Oncol (2006) 1.21
Optimized interstitial PDT prostate treatment planning with the Cimmino feasibility algorithm. Med Phys (2005) 1.18
A low molecular weight antioxidant decreases weight and lowers tumor incidence. Free Radic Biol Med (2003) 1.18
Real-time in situ monitoring of human prostate photodynamic therapy with diffuse light. Photochem Photobiol (2007) 1.17
Disparities in the treatment and outcomes of lung cancer among HIV-infected individuals. AIDS (2013) 1.16
A phase I trial of repeated intrapleural adenoviral-mediated interferon-beta gene transfer for mesothelioma and metastatic pleural effusions. Mol Ther (2010) 1.15
T cells expressing chimeric antigen receptors can cause anaphylaxis in humans. Cancer Immunol Res (2013) 1.14
Pancreatic cancer cell radiation survival and prenyltransferase inhibition: the role of K-Ras. Cancer Res (2005) 1.13
The RAS signal transduction pathway and its role in radiation sensitivity. Oncogene (2003) 1.11
NIH state-of-the-science conference statement: diagnosis and management of ductal carcinoma in situ (DCIS). NIH Consens State Sci Statements (2009) 1.10
Elective nodal irradiation (ENI) vs. involved field radiotherapy (IFRT) for locally advanced non-small cell lung cancer (NSCLC): A comparative analysis of toxicities and clinical outcomes. Radiother Oncol (2010) 1.07
Inhibition of autophagy as a strategy to augment radiosensitization by the dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitor NVP-BEZ235. Mol Pharmacol (2012) 1.04
A phase I trial of the HIV protease inhibitor nelfinavir with concurrent chemoradiotherapy for unresectable stage IIIA/IIIB non-small cell lung cancer: a report of toxicities and clinical response. J Thorac Oncol (2012) 1.04
Detection of brain tumor cells in the peripheral blood by a telomerase promoter-based assay. Cancer Res (2014) 1.03
Internal luminal pressure during early chick embryonic brain growth: descriptive and empirical observations. Anat Rec A Discov Mol Cell Evol Biol (2005) 1.03
Optimization of light source parameters in the photodynamic therapy of heterogeneous prostate. Phys Med Biol (2008) 1.03
Hypoxia and Photofrin uptake in the intraperitoneal carcinomatosis and sarcomatosis of photodynamic therapy patients. Clin Cancer Res (2004) 1.03
Cost-effectiveness of stereotactic body radiation therapy versus surgical resection for stage I non-small cell lung cancer. Cancer (2013) 1.02
Patterns of recurrence in patients treated with photodynamic therapy for intraperitoneal carcinomatosis and sarcomatosis. Int J Oncol (2004) 1.02
Tracheobronchopathia osteochondroplastica presenting as a single dominant tracheal mass. Ann Diagn Pathol (2011) 1.01
EF5 binding and clinical outcome in human soft tissue sarcomas. Int J Radiat Oncol Biol Phys (2006) 1.01
Photodynamic therapy for the treatment of non-small cell lung cancer. J Thorac Dis (2012) 0.99
Definitive radiotherapy for unresected adenoid cystic carcinoma of the trachea. Chest (2012) 0.98
The Relationship among Hypoxia, Proliferation, and Outcome in Patients with De Novo Glioblastoma: A Pilot Study. Transl Oncol (2010) 0.98
Elevated serum cytokine levels in mesothelioma patients who have undergone pleurectomy or extrapleural pneumonectomy and adjuvant intraoperative photodynamic therapy. Photochem Photobiol (2003) 0.97
Improved characterization of medically relevant fungi in the human respiratory tract using next-generation sequencing. Genome Biol (2014) 0.96
Imaging and analytical methods as applied to the evaluation of vasculature and hypoxia in human brain tumors. Radiat Res (2008) 0.94
Signaling pathways in NSCLC as a predictor of outcome and response to therapy. Lung (2004) 0.93
Biodistribution and dosimetry of (18)F-EF5 in cancer patients with preliminary comparison of (18)F-EF5 uptake versus EF5 binding in human glioblastoma. Eur J Nucl Med Mol Imaging (2010) 0.92
Cytologic accuracy of samples obtained by endobronchial ultrasound-guided transbronchial needle aspiration at Thomas Jefferson University Hospital. Acta Cytol (2008) 0.92
Adjuvant radiotherapy for completely resected stage 2 thymoma. Cancer (2011) 0.90
New strategies in non-small cell lung cancer: improving outcomes in chemoradiotherapy for locally advanced disease. Clin Cancer Res (2011) 0.88
Pilot randomized study comparing two techniques of airway anaesthesia during curvilinear probe endobronchial ultrasound bronchoscopy (CP-EBUS). Respirology (2011) 0.87
The use of proton therapy in the treatment of lung cancers. Cancer J (2014) 0.87
Effect of body mass index on magnitude of setup errors in patients treated with adjuvant radiotherapy for endometrial cancer with daily image guidance. Int J Radiat Oncol Biol Phys (2011) 0.87
A phase I trial of the dual farnesyltransferase and geranylgeranyltransferase inhibitor L-778,123 and radiotherapy for locally advanced pancreatic cancer. Clin Cancer Res (2004) 0.87
Radiation dosimetry and biodistribution of the hypoxia tracer (18)F-EF5 in oncologic patients. Cancer Biother Radiopharm (2012) 0.86
Correlation of in vivo photosensitizer fluorescence and photodynamic-therapy-induced depth of necrosis in a murine tumor model. J Biomed Opt (2003) 0.86
An in-silico comparison of proton beam and IMRT for postoperative radiotherapy in completely resected stage IIIA non-small cell lung cancer. Radiat Oncol (2013) 0.86
C225 and PDT combination therapy for ovarian cancer: the play's the thing. J Natl Cancer Inst (2005) 0.86
A case-matched study of toxicity outcomes after proton therapy and intensity-modulated radiation therapy for prostate cancer. Cancer (2014) 0.86
Prospective preference assessment of patients' willingness to participate in a randomized controlled trial of intensity-modulated radiotherapy versus proton therapy for localized prostate cancer. Int J Radiat Oncol Biol Phys (2012) 0.86
Interstitial photodynamic therapy for prostate cancer: a developing modality. Photodiagnosis Photodyn Ther (2004) 0.85
Impact of PET staging in limited-stage small-cell lung cancer. J Thorac Oncol (2013) 0.85
A research agenda for radiation oncology: results of the radiation oncology institute's comprehensive research needs assessment. Int J Radiat Oncol Biol Phys (2012) 0.84
Rates of unconventional medical therapy use in patients with prostate cancer: standard history versus directed questions. Urology (2002) 0.84
Radiation injury to the normal brain measured by 3D-echo-planar spectroscopic imaging and diffusion tensor imaging: initial experience. J Neuroimaging (2013) 0.84
Gene therapy for lung neoplasms. Clin Chest Med (2011) 0.84
Should randomized clinical trials be required for proton radiotherapy? An alternative view. J Clin Oncol (2008) 0.84
Clinical target promiscuity: lessons from ras molecular trials. Cancer Metastasis Rev (2008) 0.83
Protection against Adriamycin cytotoxicity and inhibition of DNA topoisomerase II activity by 3,4-dihydroxybenzoic acid. Int J Oncol (2003) 0.83
The body of evidence for advanced technology in radiation oncology. J Natl Cancer Inst (2012) 0.83
Dynamic simulation of motion effects in IMAT lung SBRT. Radiat Oncol (2014) 0.83
Brachial plexopathy in apical non-small cell lung cancer treated with definitive radiation: dosimetric analysis and clinical implications. Int J Radiat Oncol Biol Phys (2012) 0.82
Introduction: non-small-cell lung cancer and pleural malignancies: the end of the era of therapeutic nihilism? Semin Radiat Oncol (2010) 0.82
Diagnosis of idiopathic tracheal stenosis and treatment with papillotome electrocautery and balloon bronchoplasty. Respir Care (2011) 0.82
Endobronchial ultrasound. When to venture into the vasculature. Ann Am Thorac Soc (2013) 0.82
The role of radiation therapy in malignant thymoma: a Surveillance, Epidemiology, and End Results database analysis. J Thorac Oncol (2010) 0.82
High body mass index is associated with worse quality of life in breast cancer patients receiving radiotherapy. Breast Cancer Res Treat (2013) 0.81